CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer

Core Insights - CareDx, Inc. has appointed Dr. Jeffrey John Teuteberg as Chief Medical Officer, effective October 1, 2025, bringing over two decades of experience in clinical transplantation [1] Company Overview - CareDx, Inc. is recognized as a leading precision medicine company focused on developing and commercializing healthcare solutions specifically for transplant patients and their caregivers [1]